Conversely, in cancer, KLF9 has emerged as a tumor-suppressor by inhibiting NF-κB, repressing metastasis-associated genes like MMP9 through chromatin remodeling and direct interference with NF-κB transcriptional activity. This evidence concerns the gene KLF9 and cancer.